Nuvation Bio (NUVB) Total Current Liabilities (2020 - 2026)
Nuvation Bio (NUVB) posted quarterly Total Current Liabilities of $79.5 million for Q1 2026, up 50.69% year-over-year from $52.8 million in Q1 2025, and down 3.29% quarter-over-quarter from $82.2 million in Q4 2025.
Nuvation Bio (NUVB) Total Current Liabilities (2020 - 2026) Analysis & Trends
Nuvation Bio (NUVB) has reported Total Current Liabilities for 7 consecutive years, with $79.5 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Total Current Liabilities rose 50.69% year-over-year to $79.5 million; the TTM figure through Mar 2026 stood at $79.5 million (up 50.69% YoY), while the FY2025 annual figure was $82.2 million, up 41.18% from the prior year.
- Total Current Liabilities eased to $79.5 million in Q1 2026 per NUVB's latest filing, from $82.2 million in the prior quarter.
- Across five years, Total Current Liabilities topped out at $82.2 million in Q4 2025 and bottomed at $12.6 million in Q1 2023.
- Historically, Total Current Liabilities has averaged $38.8 million across 5 years, with a median of $21.4 million in 2022.
- Annual changes were most pronounced in 2023 — Total Current Liabilities sank 41.46% — and 2024, when it surged 316.8%.
- Nuvation Bio's Total Current Liabilities stood at $13.2 million in 2022, then rose by 6.18% to $14.0 million in 2023, then jumped by 316.8% to $58.2 million in 2024, then surged by 41.18% to $82.2 million in 2025, then declined by 3.29% to $79.5 million in 2026.
- Business Quant data shows NUVB's Total Current Liabilities at $79.5 million in Q1 2026, $82.2 million in Q4 2025, and $68.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 3.94 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 5.53 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.58 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 354.06 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 2.12 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 4.22 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 630.93 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.51 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 438.74 Mn |
| 10 | Nuvation Bio | 2.16 Bn | 2.16 Bn | 30.78 Mn | 86.76 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 86.76 Mn |
| Mar 31, 2026 | 79.52 Mn |
| Dec 31, 2025 | 82.23 Mn |
| Sep 30, 2025 | 68.13 Mn |
| Jun 30, 2025 | 66.36 Mn |
| Mar 31, 2025 | 52.77 Mn |
| Dec 31, 2024 | 58.24 Mn |
| Sep 30, 2024 | 59.04 Mn |
| Jun 30, 2024 | 51.10 Mn |
| Mar 31, 2024 | 15.76 Mn |
| Dec 31, 2023 | 13.97 Mn |
| Sep 30, 2023 | 16.14 Mn |
| Jun 30, 2023 | 13.41 Mn |
| Mar 31, 2023 | 12.55 Mn |
| Dec 31, 2022 | 13.16 Mn |
| Sep 30, 2022 | 14.01 Mn |
| Jun 30, 2022 | 21.27 Mn |
| Mar 31, 2022 | 21.44 Mn |
| Dec 31, 2021 | 16.93 Mn |
| Sep 30, 2021 | 13.31 Mn |